SPAC823.11 Antibody

What is SPAC823.11 and why is it significant for research?

SPAC823.11 is a protein-coding gene in Schizosaccharomyces pombe (fission yeast) with Entrez Gene ID 2543496. It encodes a putative sphingosine-1-phosphate phosphatase that plays a crucial role in sphingolipid metabolism. This protein is significant for research because sphingolipid metabolism is highly conserved across eukaryotes and involved in numerous cellular processes including cell growth, differentiation, and stress responses. The protein is encoded by mRNA transcript NM_001019267.2 and is identified as protein NP_593838.1 in databases . Understanding SPAC823.11 function provides insights into fundamental cellular processes that may be translated to higher eukaryotes including humans.

What are the known homologs of SPAC823.11 in other organisms?

SPAC823.11 has several identified homologs across different organisms, indicating its evolutionary conservation and biological importance. Key homologs include:

The presence of homologs in both fungi and plants demonstrates the fundamental importance of this enzyme class across diverse eukaryotic lineages . Researchers often use comparative studies across these homologs to elucidate conserved functional domains and regulatory mechanisms.

What types of antibodies are available for studying SPAC823.11?

For studying SPAC823.11, researchers can utilize several types of antibodies:

• Polyclonal antibodies: Generated against multiple epitopes of SPAC823.11, providing high sensitivity but potentially less specificity

• Monoclonal antibodies: Target specific epitopes, offering high specificity and reproducibility

• Epitope-tagged antibodies: Used with recombinant SPAC823.11 proteins containing tags (His, FLAG, or HA)

• Phospho-specific antibodies: Detect phosphorylated forms of SPAC823.11 if post-translational modifications are being studied

When selecting antibodies for SPAC823.11 research, it's essential to verify specificity through appropriate controls, including knockout strains lacking the SPAC823.11 gene, as cross-reactivity with related phosphatases can occur. Western blotting validation using both wild-type and mutant strains is recommended before proceeding to more complex applications.

How can SPAC823.11 antibodies be used to study sphingolipid metabolism in fission yeast?

SPAC823.11 antibodies offer powerful tools for investigating sphingolipid metabolism through multiple methodological approaches:

• Immunoprecipitation coupled with mass spectrometry: This approach enables identification of SPAC823.11 interaction partners, revealing its functional complexes and regulatory networks. By precipitating SPAC823.11 from yeast lysates under various conditions (nutrient starvation, osmotic stress, etc.), researchers can map condition-dependent protein interactions.

• Chromatin immunoprecipitation (ChIP): If SPAC823.11 has nuclear functions, ChIP can determine if it associates with specific genomic regions either directly or as part of regulatory complexes.

• Subcellular localization studies: Immunofluorescence using SPAC823.11 antibodies can track the protein's localization under different conditions, revealing transport mechanisms and functional compartmentalization.

• Quantitative Western blotting: To measure expression levels across growth phases, stress conditions, or genetic backgrounds, providing insights into regulatory mechanisms.

These techniques collectively allow researchers to build comprehensive models of sphingolipid metabolism and its integration with other cellular processes in S. pombe, potentially identifying novel regulatory mechanisms conserved in higher eukaryotes.

What considerations are important when designing co-immunoprecipitation experiments with SPAC823.11 antibodies?

Designing effective co-immunoprecipitation (co-IP) experiments for SPAC823.11 requires careful consideration of several key factors:

• Lysis buffer optimization: Since SPAC823.11 is a membrane-associated phosphatase, lysis conditions must balance protein solubilization with maintaining native interactions. A comparative approach testing different detergents (0.5-1% NP-40, 0.1-0.5% Triton X-100, or gentler detergents like digitonin) is recommended.

• Cross-linking strategies: For transient interactions, implementing crosslinking with formaldehyde (0.1-1%) or DSP (dithiobis[succinimidyl propionate]) before lysis can preserve interactions that might otherwise be lost.

• Negative controls: Include parallel IPs with:

  • Non-specific IgG antibodies

  • Lysate from SPAC823.11 deletion strains

  • Competitive epitope blocking with immunizing peptides

• Validation methods: All interactions should be validated by reciprocal co-IP (using antibodies against the interacting partner) and alternative methods like proximity ligation assays or fluorescence resonance energy transfer (FRET).

• Experimental conditions: Test multiple physiological states (exponential growth, stationary phase, stress conditions) as SPAC823.11 interactions may be condition-dependent.

Careful optimization of these parameters will maximize the detection of genuine interaction partners while minimizing false positives and negatives.

How can SPAC823.11 antibodies contribute to studies of evolutionary conservation of sphingolipid metabolism?

SPAC823.11 antibodies provide valuable tools for comparative evolutionary studies across species through several approaches:

• Cross-reactivity testing: Examining whether SPAC823.11 antibodies recognize homologous proteins in related species (using Western blots of lysates from S. cerevisiae, other yeasts, and potentially higher eukaryotes) can help identify conserved epitopes.

• Functional complementation analysis: Combined with genetic approaches where homologs from other species are expressed in SPAC823.11-deleted S. pombe strains, antibodies can verify expression levels and localization patterns of these heterologous proteins.

• Comparative immunoprecipitation: Performing parallel IPs using the same antibody against homologs in different species (when possible) allows comparison of interaction networks, revealing which protein-protein interactions are evolutionarily conserved.

• Conservation mapping: By combining epitope mapping data with sequence analysis across homologs in different species, researchers can identify highly conserved functional domains versus species-specific regions, providing insights into evolutionary adaptation.

These approaches help establish which aspects of sphingolipid phosphatase function and regulation have been conserved throughout evolution, potentially identifying critical nodes in sphingolipid metabolism that may represent therapeutic targets in pathogenic fungi or disease models.

What is the optimal protocol for Western blotting detection of SPAC823.11?

The optimal Western blotting protocol for SPAC823.11 detection requires special attention to several key steps:

• Sample preparation:

  • Harvest cells in mid-log phase (OD600 0.5-0.8)

  • Lyse cells using glass bead disruption in buffer containing 50mM Tris-HCl pH 7.5, 150mM NaCl, 1% Triton X-100, 1mM EDTA, and protease inhibitor cocktail

  • Include phosphatase inhibitors (10mM NaF, 1mM Na3VO4) if phosphorylation status is relevant

• Protein separation:

  • Use 10-12% SDS-PAGE gels for optimal resolution

  • Load 20-50μg of total protein per lane

  • Include positive control (tagged SPAC823.11) and negative control (ΔSPAC823.11 strain lysate)

• Transfer conditions:

  • Semi-dry transfer at 15V for 45 minutes or wet transfer at 100V for 1 hour

  • Use PVDF membrane (preferred over nitrocellulose for this protein)

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Primary antibody dilution: 1:1000 to 1:2000, incubate overnight at 4°C

  • Wash 3x10 minutes with TBST

  • Secondary antibody dilution: 1:5000, incubate 1 hour at room temperature

• Detection:

  • Enhanced chemiluminescence is typically sufficient

  • Expected molecular weight: approximately 43-45 kDa

For challenging applications, optimization of lysis conditions may be necessary, particularly if SPAC823.11 is associated with membrane fractions or specialized compartments.

What approaches can be used for immunofluorescence localization of SPAC823.11 in fission yeast?

Successful immunofluorescence localization of SPAC823.11 in S. pombe requires careful attention to fixation and permeabilization methods:

This protocol can be adapted for co-localization studies with markers of sphingolipid metabolism, providing insights into the spatial organization of this pathway in S. pombe.

What methods are recommended for validating SPAC823.11 antibody specificity?

Rigorous validation of SPAC823.11 antibody specificity is essential for reliable research outcomes. Recommended methods include:

• Genetic validation:

  • Western blot comparison between wild-type and ΔSPAC823.11 deletion strains

  • Analysis of strains with controlled SPAC823.11 overexpression

  • Testing against strains expressing epitope-tagged SPAC823.11 (detection with both anti-SPAC823.11 and anti-tag antibodies)

• Biochemical validation:

  • Peptide competition assay: pre-incubation of antibody with immunizing peptide should eliminate specific signal

  • Immunoprecipitation followed by mass spectrometry to confirm target identity

  • Depletion assay: sequential immunoprecipitations should progressively reduce SPAC823.11 signal

• Cross-reactivity assessment:

  • Test against recombinant homologs (S. cerevisiae LCB3/YSR3) to evaluate specificity

  • Test against proteins with similar domains to assess potential cross-reactivity

• Application-specific validation:

  • For immunofluorescence: compare patterns with SPAC823.11-GFP fusion proteins

  • For ChIP: include non-target genomic regions as negative controls

  • For activity assays: confirm that immunodepletion reduces enzymatic activity proportionally

A comprehensive validation approach combines multiple methods and documents antibody performance across different experimental conditions and applications, ensuring reliable and reproducible results.

How can researchers resolve inconsistent detection of SPAC823.11 in Western blots?

Inconsistent detection of SPAC823.11 in Western blots is a common challenge that can be addressed through systematic troubleshooting:

• Protein extraction optimization:

  • SPAC823.11, as a membrane-associated phosphatase, may require specialized extraction methods

  • Compare different lysis methods: glass bead disruption, enzymatic spheroplasting, or cryogenic grinding

  • Test modified buffers with varying detergent compositions (CHAPS, digitonin, or deoxycholate in addition to standard Triton X-100)

• Protein degradation prevention:

  • Enhance protease inhibitor cocktails with specific inhibitors like PMSF (1mM), leupeptin (10μg/ml), and pepstatin A (1μg/ml)

  • Maintain samples at 4°C throughout processing

  • Consider adding N-ethylmaleimide (5mM) to prevent post-lysis modifications

• Antibody optimization:

  • Test different antibody concentrations (1:500 to 1:5000 dilution series)

  • Extend primary antibody incubation time (overnight at 4°C versus 2 hours at room temperature)

  • Try different blocking agents (5% BSA may be superior to milk for phosphoproteins)

• Signal enhancement strategies:

  • Use high-sensitivity ECL substrates for chemiluminescence detection

  • Consider signal amplification systems like tyramide signal amplification

  • Optimize exposure times based on quantitative assessment of signal-to-noise ratio

• Sample enrichment approaches:

  • Perform subcellular fractionation to concentrate membrane fractions

  • Use immunoprecipitation to enrich SPAC823.11 before Western blotting

By systematically addressing these factors, researchers can establish reliable and consistent SPAC823.11 detection protocols tailored to their specific experimental conditions.

What are the common pitfalls in interpreting SPAC823.11 subcellular localization data?

Interpreting SPAC823.11 subcellular localization data requires awareness of several potential pitfalls:

• Fixation artifacts:

  • Different fixation methods can alter apparent localization patterns

  • Solution: Compare multiple fixation protocols (formaldehyde, methanol, glutaraldehyde) and confirm with live-cell imaging of fluorescently-tagged proteins

• Overexpression effects:

  • Overexpressed SPAC823.11 may mislocalize due to saturation of normal trafficking pathways

  • Solution: Use native promoter expression systems and compare with antibody detection of endogenous protein

• Cell cycle variations:

  • SPAC823.11 localization may change throughout the cell cycle

  • Solution: Synchronize cultures or use cell cycle phase markers to categorize observations

• Stress-induced relocalization:

  • Sample preparation itself may trigger stress responses altering normal localization

  • Solution: Implement rapid fixation protocols and compare with conditions mimicking specific stresses

• Resolution limitations:

  • Standard fluorescence microscopy may not resolve closely associated compartments

  • Solution: Employ super-resolution techniques (STED, PALM, or SIM) for ambiguous patterns

• Background fluorescence interference:

  • S. pombe cell walls can generate autofluorescence

  • Solution: Include unstained controls and consider spectral unmixing for multicolor imaging

When reporting localization data, researchers should clearly specify cell culture conditions, fixation methods, microscopy parameters, and quantification approaches to enable proper interpretation and reproducibility of findings.

How should researchers analyze and interpret SPAC823.11 phosphatase activity data?

Analysis and interpretation of SPAC823.11 phosphatase activity require careful experimental design and data processing:

• Substrate selection considerations:

  • Use purified sphingosine-1-phosphate as physiological substrate

  • Include control substrates (p-nitrophenyl phosphate) to assess general phosphatase activity

  • Consider fluorescent or radioactive substrates for increased sensitivity

• Activity normalization strategies:

  • Normalize to total protein concentration in crude extracts

  • For immunoprecipitated SPAC823.11, quantify protein amounts by Western blot densitometry

  • Express activity as specific activity (nmol/min/mg protein)

• Essential controls:

  • Negative controls: heat-inactivated enzyme, ΔSPAC823.11 strain extracts

  • Phosphatase inhibitor panel: test sensitivity to different inhibitor classes to confirm specificity

  • Substrate competition: non-hydrolyzable analogs should competitively inhibit activity

• Kinetic parameter determination:

  • Generate Michaelis-Menten plots across substrate concentrations (1-100μM)

  • Calculate Km and Vmax using non-linear regression (avoid Lineweaver-Burk plots)

  • Compare parameters across conditions to identify regulatory mechanisms

• Data presentation standards:

  • Report activity with defined reaction conditions (pH, temperature, buffer composition)

  • Include time-course data to confirm linearity during the measurement period

  • Present both raw data and processed results for transparency

By addressing these analytical considerations, researchers can generate robust and reproducible enzymatic data that accurately reflects SPAC823.11's biological activity and regulation.

How does SPAC823.11 function compare to its homologs in Saccharomyces cerevisiae?

SPAC823.11 in S. pombe shares functional homology with two S. cerevisiae proteins: LCB3 (NP_012401.1) and YSR3 (NP_012979.3) . Comparative studies reveal important similarities and differences:

• Enzymatic activity profiles:

  • All three enzymes dephosphorylate sphingoid base phosphates, but with different substrate preferences

  • SPAC823.11 shows broader substrate specificity than either cerevisiae homolog

  • Kinetic parameters (Km, Vmax) differ significantly under identical assay conditions

• Subcellular localization patterns:

  • LCB3: Primarily endoplasmic reticulum-associated

  • YSR3: Distributed between ER and vacuolar membranes

  • SPAC823.11: More dynamic localization responding to cellular conditions

• Regulation mechanisms:

  • LCB3 expression responds primarily to ER stress

  • YSR3 is regulated by heat shock and nitrogen availability

  • SPAC823.11 shows more complex regulation integrating multiple stress signals

• Phenotypic consequences of deletion:

  • ΔSPAC823.11 strains show distinct phenotypic profiles compared to Δlcb3 or Δysr3 strains

  • Double deletion of LCB3/YSR3 more closely resembles ΔSPAC823.11 phenotype, suggesting functional consolidation in S. pombe

These comparative analyses highlight evolutionary divergence in sphingolipid metabolism regulation between the two yeast species, with S. pombe potentially representing an intermediate evolutionary stage between S. cerevisiae and higher eukaryotes in pathway organization.

What emerging technologies might enhance SPAC823.11 antibody-based research?

Several emerging technologies show promise for advancing SPAC823.11 antibody-based research:

• Proximity labeling techniques:

  • BioID or TurboID fusion constructs with SPAC823.11 allow in vivo biotinylation of proximal proteins

  • APEX2 fusions enable electron microscopy-compatible proximity labeling

  • These approaches identify transient interactions and spatial relationships not captured by co-immunoprecipitation

• Single-molecule imaging approaches:

  • Super-resolution microscopy (PALM/STORM) using photoconvertible fluorophore-conjugated antibodies

  • Single-particle tracking to monitor SPAC823.11 dynamics in living cells

  • Correlative light-electron microscopy for nanoscale contextualization

• Nanobody and single-domain antibody development:

  • Smaller antibody fragments with enhanced penetration of yeast cell walls

  • Intrabodies expressed within cells to track and potentially modulate SPAC823.11 in vivo

  • Multiplexed epitope detection through orthogonal nanobody labeling

• Mass cytometry (CyTOF) applications:

  • Metal-conjugated antibodies for highly multiplexed detection of SPAC823.11 and associated proteins

  • Single-cell resolution of sphingolipid metabolism components across populations

  • Integration with transcriptomics for multi-omic profiling

• Antibody-enabled optogenetic control:

  • Photocaged antibodies for temporal control of SPAC823.11 inhibition

  • Optogenetic recruitment systems using antibody-based targeting modules

These technologies extend beyond traditional antibody applications, offering unprecedented insights into SPAC823.11 dynamics, interactions, and functions within the complex cellular environment.

How can integrative approaches combining antibody-based detection with omics data enhance understanding of SPAC823.11 function?

Integrative multi-omic approaches can dramatically enhance understanding of SPAC823.11 function:

• Antibody-ChIP integration with transcriptomics:

  • ChIP-seq using SPAC823.11 antibodies identifies genomic binding sites if nuclear functions exist

  • Integration with RNA-seq in wild-type versus ΔSPAC823.11 strains connects binding events to transcriptional outcomes

  • GRO-seq or NET-seq can distinguish direct versus indirect transcriptional effects

• Immunoprecipitation-mass spectrometry with phosphoproteomics:

  • Quantitative proteomics identifying condition-dependent SPAC823.11 interaction partners

  • Parallel phosphoproteomic analysis revealing signaling networks affected by SPAC823.11 activity

  • Kinetic analysis of phosphorylation changes following acute SPAC823.11 inhibition

• Spatial proteomics integration:

  • Proximity labeling with multiplexed protein quantification

  • Subcellular fractionation with targeted antibody detection

  • Correlation with lipidomic profiles of corresponding cellular compartments

• Systems-level network analysis:

  • Bayesian network modeling incorporating antibody-derived interaction data

  • Comparison of perturbation signatures across genetic and antibody-mediated inhibitions

  • Cross-species comparative network analysis using homologous proteins

• Temporal dynamics studies:

  • Time-resolved antibody-based measurements across stress responses

  • Integration with metabolic flux analysis of sphingolipid pathways

  • Mathematical modeling of SPAC823.11 contribution to sphingolipid homeostasis

These integrative approaches transform static antibody-based observations into dynamic, systems-level understanding of SPAC823.11's role in cellular physiology, potentially revealing unexpected functions beyond its annotated role as a sphingosine-1-phosphate phosphatase.